Forte Biosciences, Inc. (FBRX) Long-Term Debt Issuances (2016 - 2017)
Forte Biosciences (FBRX) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $7.3 million as the latest value for Q1 2017.
- On a quarterly basis, Long-Term Debt Issuances changed N/A to $7.3 million in Q1 2017 year-over-year; TTM through Dec 2017 was $7.3 million, a N/A change, with the full-year FY2017 number at $7.3 million, up 117.49% from a year prior.
- Long-Term Debt Issuances was $7.3 million for Q1 2017 at Forte Biosciences, up from $2.8 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $7.3 million in Q1 2017 to a low of $2.8 million in Q4 2016.